Učitavanje...
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
BACKGROUND: Prostate cancer is one of the most prevalent cancers in males in the United States and amongst the leading causes of cancer related deaths. A particularly virulent form of this disease is castration-resistant prostate cancer (CRPC), where patients no longer respond to medical or surgical...
Spremljeno u:
| Izdano u: | BMC Bioinformatics |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5374594/ https://ncbi.nlm.nih.gov/pubmed/28361666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-017-1522-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|